Literature DB >> 34202107

Modeling the Impact of COVID-19 Vaccination in Lebanon: A Call to Speed-Up Vaccine Roll Out.

Ghina R Mumtaz1,2, Fadi El-Jardali3,4,5, Mathilda Jabbour3,4, Aya Harb3,4, Laith J Abu-Raddad6,7, Monia Makhoul6,7.   

Abstract

Four months into the SARS-CoV-2 vaccination campaign, only 10.7% of the Lebanese population have received at least one dose, raising serious concerns over the speed of vaccine roll-out and its impact in the event of a future surge. Using mathematical modeling, we assessed the short-term impact of various vaccine roll-out scenarios on SARS-CoV-2 epidemic course in Lebanon. At current population immunity levels, estimated by the model at 40% on 15 April 2021, a large epidemic wave is predicted if all social distancing restrictions are gradually eased and variants of concern are introduced. Reaching 80% vaccine coverage by the end of 2021 will flatten the epidemic curve and will result in a 37% and 34% decrease in the peak daily numbers of severe/critical disease cases and deaths, respectively; while reaching intermediate coverage of 40% will result in only a 10-11% decrease in each. Reaching 80% vaccine coverage by August would prevent twice as many severe/critical disease cases and deaths than if it were reached by December. Easing restrictions over a longer duration resulted in more favorable vaccination impact. In conclusion, for vaccination to have impact in the short-term, scale-up has to be rapid and reach high coverage (at least 70%), while sustaining social distancing measures during roll-out. At current vaccination pace, this is unlikely to be achieved. Concerted efforts need to be made to overcome local challenges and substantially scale up vaccination to avoid a surge that the country, with its multiple crises and limited health-care capacity, is largely unprepared for.

Entities:  

Keywords:  COVID-19; Lebanon; SARS-CoV-2; coronavirus; epidemiology; mathematical model; vaccine

Year:  2021        PMID: 34202107     DOI: 10.3390/vaccines9070697

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  17 in total

1.  Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.

Authors:  Denis Y Logunov; Inna V Dolzhikova; Dmitry V Shcheblyakov; Amir I Tukhvatulin; Olga V Zubkova; Alina S Dzharullaeva; Anna V Kovyrshina; Nadezhda L Lubenets; Daria M Grousova; Alina S Erokhova; Andrei G Botikov; Fatima M Izhaeva; Olga Popova; Tatiana A Ozharovskaya; Ilias B Esmagambetov; Irina A Favorskaya; Denis I Zrelkin; Daria V Voronina; Dmitry N Shcherbinin; Alexander S Semikhin; Yana V Simakova; Elizaveta A Tokarskaya; Daria A Egorova; Maksim M Shmarov; Natalia A Nikitenko; Vladimir A Gushchin; Elena A Smolyarchuk; Sergey K Zyryanov; Sergei V Borisevich; Boris S Naroditsky; Alexander L Gintsburg
Journal:  Lancet       Date:  2021-02-02       Impact factor: 79.321

2.  Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Authors:  Merryn Voysey; Sue Ann Costa Clemens; Shabir A Madhi; Lily Y Weckx; Pedro M Folegatti; Parvinder K Aley; Brian Angus; Vicky L Baillie; Shaun L Barnabas; Qasim E Bhorat; Sagida Bibi; Carmen Briner; Paola Cicconi; Andrea M Collins; Rachel Colin-Jones; Clare L Cutland; Thomas C Darton; Keertan Dheda; Christopher J A Duncan; Katherine R W Emary; Katie J Ewer; Lee Fairlie; Saul N Faust; Shuo Feng; Daniela M Ferreira; Adam Finn; Anna L Goodman; Catherine M Green; Christopher A Green; Paul T Heath; Catherine Hill; Helen Hill; Ian Hirsch; Susanne H C Hodgson; Alane Izu; Susan Jackson; Daniel Jenkin; Carina C D Joe; Simon Kerridge; Anthonet Koen; Gaurav Kwatra; Rajeka Lazarus; Alison M Lawrie; Alice Lelliott; Vincenzo Libri; Patrick J Lillie; Raburn Mallory; Ana V A Mendes; Eveline P Milan; Angela M Minassian; Alastair McGregor; Hazel Morrison; Yama F Mujadidi; Anusha Nana; Peter J O'Reilly; Sherman D Padayachee; Ana Pittella; Emma Plested; Katrina M Pollock; Maheshi N Ramasamy; Sarah Rhead; Alexandre V Schwarzbold; Nisha Singh; Andrew Smith; Rinn Song; Matthew D Snape; Eduardo Sprinz; Rebecca K Sutherland; Richard Tarrant; Emma C Thomson; M Estée Török; Mark Toshner; David P J Turner; Johan Vekemans; Tonya L Villafana; Marion E E Watson; Christopher J Williams; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal:  Lancet       Date:  2020-12-08       Impact factor: 79.321

3.  SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy.

Authors:  Laith J Abu-Raddad; Hiam Chemaitelly; Peter Coyle; Joel A Malek; Ayeda A Ahmed; Yasmin A Mohamoud; Shameem Younuskunju; Houssein H Ayoub; Zaina Al Kanaani; Einas Al Kuwari; Adeel A Butt; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul Rahim; Gheyath K Nasrallah; Hadi M Yassine; Mohamed Ghaith Al Kuwari; Hamad Eid Al Romaihi; Mohamed H Al-Thani; Abdullatif Al Khal; Roberto Bertollini
Journal:  EClinicalMedicine       Date:  2021-04-28

4.  Vulnerability of Syrian refugees in Lebanon to COVID-19: quantitative insights.

Authors:  Fouad M Fouad; Stephen J McCall; Houssein Ayoub; Laith J Abu-Raddad; Ghina R Mumtaz
Journal:  Confl Health       Date:  2021-03-05       Impact factor: 2.723

5.  Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.

Authors:  Kate M Bubar; Kyle Reinholt; Stephen M Kissler; Marc Lipsitch; Sarah Cobey; Yonatan H Grad; Daniel B Larremore
Journal:  Science       Date:  2021-01-21       Impact factor: 47.728

6.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

Authors:  Noa Dagan; Noam Barda; Eldad Kepten; Oren Miron; Shay Perchik; Mark A Katz; Miguel A Hernán; Marc Lipsitch; Ben Reis; Ran D Balicer
Journal:  N Engl J Med       Date:  2021-02-24       Impact factor: 91.245

7.  Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.

Authors:  Nathan D Grubaugh; William P Hanage; Angela L Rasmussen
Journal:  Cell       Date:  2020-07-03       Impact factor: 41.582

8.  Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.

Authors:  Ania Wajnberg; Fatima Amanat; Adolfo Firpo; Deena R Altman; Mark J Bailey; Mayce Mansour; Meagan McMahon; Philip Meade; Damodara Rao Mendu; Kimberly Muellers; Daniel Stadlbauer; Kimberly Stone; Shirin Strohmeier; Viviana Simon; Judith Aberg; David L Reich; Florian Krammer; Carlos Cordon-Cardo
Journal:  Science       Date:  2020-10-28       Impact factor: 47.728

9.  Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China.

Authors:  Monia Makhoul; Hiam Chemaitelly; Houssein H Ayoub; Shaheen Seedat; Laith J Abu-Raddad
Journal:  Vaccines (Basel)       Date:  2021-03-05

10.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors:  Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal:  Cell       Date:  2020-07-03       Impact factor: 66.850

View more
  3 in total

1.  Booster Vaccination Strategies for "Living With COVID-19".

Authors:  Jung Eun Kim; Sunmi Lee; Hee-Sung Kim
Journal:  Front Public Health       Date:  2022-06-03

Review 2.  Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.

Authors:  Iman Dandachi; Waleed Aljabr
Journal:  Front Microbiol       Date:  2022-08-31       Impact factor: 6.064

3.  The Role of Lebanon in the COVID-19 Butterfly Effect: The B.1.398 Example.

Authors:  Dalal Nour; Rayane Rafei; Alessandra P Lamarca; Luiz G P de Almeida; Marwan Osman; Mohamad Bachar Ismail; Hassan Mallat; Atika Berry; Gwendolyne Burfin; Quentin Semanas; Laurence Josset; Hamad Hassan; Fouad Dabboussi; Bruno Lina; Philippe Colson; Ana Tereza R Vasconcelos; Monzer Hamze
Journal:  Viruses       Date:  2022-07-27       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.